James J. Grady

Does Daily Moderate-to-Vigorous Physical Activity Affect Glycemic Control Equally Across Populations? Insights From NHANES 2005–2006

Z. Helen Wu, Yunqi Wang, Taiwo F. Ajibola, Helen Swede et autres

Current physical activity (PA) guidelines for chronic disease management (e.g., diabetes) are based on population averages and may not reflect physiological differences across racial/ethnic groups. This study investigates whether the association between PA and glycemic control varies among Non-Hispanic White (NHW), Non-Hispanic …

us (code pays fourni par la source)

Acceptability, Feasibility, and Preliminary Efficacy of a Digital Cognitive Intervention for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) in Older Adults

Cutter A. Lindbergh, Roger Altizer, James J. Grady, Holly E. Eddy et autres

us (code pays fourni par la source)

Supplementary Table S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S1: List of food items study participants were asked to avoid during the 7-day washout period and 3-week walnut supplementation.

Supplementary Table S4 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S4: Antibodies used for IMC analysis.

Supplementary Figure S3 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Figure S3: Positive correlation between fecal and urinary urolithin A levels

Supplementary Table S8 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S8: Baseline sociodemographic characteristics of 38 study participants based on urinary urolithin A production

Supplementary Table S5 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S5: Polyp risk score association with urolithin production

Supplementary Table S9 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S9: Non-hydrolyzed fecal urolithin A levels

Supplementary Table S7 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S7: Adjusted dietary intake of 38 study participants based on urinary urolithin A production post walnut intervention

Supplementary Table S10 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Table S10: Representativeness of Study Participants

Supplementary Figure S2 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Figure S2: Polyp tissues used for IMC analysis

Supplementary Figure S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A

Marmar R. Moussa, Nuoxi Fan, John Birk, Anthony A. Provatas et autres

Supplementary Figure S1: Selection of study participants